References
- Genazzani AR, Pluchino N. DHEA therapy in postmenopausal women: the need to move forward beyond the lack of evidence. Climacteric 2010;13:314–16
- Labrie F, Labrie C. DHEA and intracrinology at menopause, a positive choice for evolution of the human species. Climacteric 2013;16:205–13
- Butenandt A, Dannenbaum H. Uber Androsteron III. Isolier- ung eines neuen physiologisch unwirksamen Sterinderivates aus Mannerharn, seine Verknupfung mit Dehydro-androsteron und Androsteron: ein Beitrag zur Konsitution des Androsterones. Z Physiol Chem 1934;229:192–5
- Migeon CJ, Plager JE. Identification and isolation of dehydroepiandrosterone from peripheral human plasma. J Biol Chem 1954;209:767–72
- Davis SR, Panjari M, Stanczwk. DHEA replacement for postmenopausal women. J Clin Endocrinol Metab 2011;96: 1642–53
- Arlt W. The approach to the adult with newly diagnosed adrenal insufficiency. J Clin Endocrinol Metab 2009;94: 1059–67
- Yeung TWY, Li RHW, Lee VCY, Ho PC, Ng EHY. A randomized double-blind placebo-controlled trial on the effect of dehydroepiandrosterone for 16 weeks on ovarian response markers in women with primary ovarian insufficiency. J Clin Endocrinol Metab 2013;98:380–8
- IVF Worldwide Survey. Poor responders: how to define, diagnose and treat? 2010www.IVF-Worldwide.com